Animal studies have shown that Piezo1 antagonists can effectively inhibit inflammation, protect neurons, and suggest its potential clinical application value in neuroprotection and delaying the progression of neurodegenerative diseases (Sun et al., 2024; Xu T. et al., 2025). The gene discussed is PIEZO1; the disease is neurodegenerative disease.